Activin and Inhibin

HPK1-IN-3 is a potent and selective ATP-competitive hematopoietic progenitor kinase 1 (HPK1: MAP4K1) inhibitor with an IC 50 of 0.25 nM. HPK1-IN-3 has IL-2 cellular potency with an EC 50 of 108 nM in human peripheral blood mononuclear cells

HPK1-IN-3 is a potent and selective ATP-competitive hematopoietic progenitor kinase 1 (HPK1: MAP4K1) inhibitor with an IC 50 of 0.25 nM. HPK1-IN-3 has IL-2 cellular potency with an EC 50 of 108 nM in human peripheral blood mononuclear cells

HPK1-IN-32 is a potent and selective HPK1 inhibitor with an IC 50 of 65 nM. HPK1-IN-32 can be used for the research of HPK1 related disorders or diseasesIn VitroHPK1-IN-32 (Example A34, 0-2 μM, 2 h) inhibits cellular pSLP76 activity with an IC 50 of

HPK1-IN-32 is a potent and selective HPK1 inhibitor with an IC 50 of 65 nM. HPK1-IN-32 can be used for the research of HPK1 related disorders or diseasesIn VitroHPK1-IN-32 (Example A34, 0-2 μM, 2 h) inhibits cellular pSLP76 activity with an IC 50 of

HPK1-IN-32 is a potent and selective HPK1 inhibitor with an IC 50 of 65 nM. HPK1-IN-32 can be used for the research of HPK1 related disorders or diseasesIn VitroHPK1-IN-32 (Example A34, 0-2 μM, 2 h) inhibits cellular pSLP76 activity with an IC 50 of

HPK1-IN-34 (Compound 143) is a Hematopoietic progenitor kinase 1 ( HPK1 ) inhibitor with an IC 50 of &lt:100 nMForm:SolidIC50&amp: Target:HPK1 &lt:100 nM (IC 50 ).

HPK1-IN-34 (Compound 143) is a Hematopoietic progenitor kinase 1 ( HPK1 ) inhibitor with an IC 50 of &lt:100 nMForm:SolidIC50&amp: Target:HPK1 &lt:100 nM (IC 50 ).

HPK1-IN-34 (Compound 143) is a Hematopoietic progenitor kinase 1 ( HPK1 ) inhibitor with an IC 50 of &lt:100 nMForm:SolidIC50&amp: Target:HPK1 &lt:100 nM (IC 50 ).

HPK1-IN-4 (comp 22) is a HPK1 (MAPK41) inhibitor ( IC 50 of 0.061 nM) as preclinical immunoresearch tool compoundForm:SolidIC50&amp: Target:IC50: 0.061 nM (HPK1).

HPK1-IN-4 (comp 22) is a HPK1 (MAPK41) inhibitor ( IC 50 of 0.061 nM) as preclinical immunoresearch tool compoundForm:SolidIC50&amp: Target:IC50: 0.061 nM (HPK1).

HPK1-IN-4 (comp 22) is a HPK1 (MAPK41) inhibitor ( IC 50 of 0.061 nM) as preclinical immunoresearch tool compoundIC50&amp: Target:IC50: 0.061 nM (HPK1).

HPK1-IN-7 is a potent, orally active HPK1 (hematopoietic progenitor kinase 1, MAP4K1) inhibitor ( IC 50 =2.6 nM) with excellent family and kinome selectivity. HPK1-IN-7 shows selectivity against IRAK4 (59 nM) and GLK (140 nM). HPK1-IN-7 shows robust